Is CLSN or QYLD a better dividend investment in 2026?

CLSN currently yields 102.74% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: CLSN offers higher current income.

What is the dividend yield difference between CLSN and QYLD?

CLSN has a forward dividend yield of 102.74% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 90.82 percentage points.

Home › Compare › CLSN vs QYLD

CLSN vs QYLD: Dividend Comparison 2026

CLSN yields 102.74% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLSN wins by $4.33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLSN

● Live price

102.74%

Share price

$1.95

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.36M

Annual income

$1,494,304.71

Full CLSN calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — CLSN vs QYLD

📍 CLSN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLSN	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLSN + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLSN pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLSN

Annual income on $10K today (after 15% tax)

$8,733.18/yr

After 10yr DRIP, annual income (after tax)

$1,270,159.00/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, CLSN beats the other by $1,265,348.59/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLSN + QYLD for your $10,000?

CLSN: 50%QYLD: 50%

100% QYLD50/50100% CLSN

Portfolio after 10yr

$2.19M

Annual income

$749,982.01/yr

Blended yield

34.24%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CLSN right now

CLSN

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-7819.1

Piotroski

3/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLSN buys

QYLD buys

Politician	Chamber	Ticker	Type	Amount	Date
Tim Moore	🏢 House	$QYLD	▼ Sell	$15,001 - $50,000	2025-05-02
Tim Moore	🏢 House	$QYLD	▲ Buy	$15,001 - $50,000	2025-04-07
Dwight Evans	🏢 House	$QYLD	▼ Sell	$1,001 - $15,000	2022-11-14
Dwight Evans	🏢 House	$QYLD	▼ Sell	$1,001 - $15,000	2020-10-29

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLSNQYLD

Forward yield	102.74% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.36M	$25.4K ✓
Annual income after 10y	$1,494,304.71 ✓	$5,659.31
Total dividends collected	$3.90M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CLSN vs QYLD ($10,000, DRIP)

Year	CLSN Portfolio	CLSN Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$20,974	$10,274.32	$10,352	$1,192.36	+$10.6K → CLSN
2	$42,582	$20,139.91	$10,830	$1,347.57	+$31.8K → CLSN
3	$83,777	$38,213.45	$11,460	$1,539.07	+$72.3K → CLSN
4	$159,904	$70,262.72	$12,275	$1,777.84	+$147.6K → CLSN
5	$296,433	$125,336.27	$13,323	$2,078.95	+$283.1K → CLSN
6	$534,334	$217,150.75	$14,667	$2,463.34	+$519.7K → CLSN
7	$937,555	$365,816.85	$16,396	$2,960.57	+$921.2K → CLSN
8	$1,603,062	$599,878.65	$18,631	$3,612.97	+$1.58M → CLSN
9	$2,673,868	$958,591.11	$21,548	$4,482.15	+$2.65M → CLSN
10	$4,355,343	$1,494,304.71	$25,398	$5,659.31	+$4.33M → CLSN

CLSN vs QYLD: Complete Analysis 2026

CLSN — Stock

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Full CLSN Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this CLSN vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLSN vs SCHD CLSN vs JEPI CLSN vs O CLSN vs KO CLSN vs MAIN CLSN vs XYLD CLSN vs JEPQ CLSN vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.